Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2010
08/04/2010CN101791338A Medicament for resisting influenza and preparation method and application thereof
08/04/2010CN101791328A Traditional Chinese medicine oral liquid for treating swine eperythrozoonosis and preparation method thereof
08/04/2010CN101791327A Natural antibiotics comprising bee-venoms and crude drug-extracts and preparing method thereof
08/04/2010CN101791319A Female pudendum nursing product
08/04/2010CN101791301A Application of diallyl disulphide in preparing broad-spectrum antiviral medicament
08/04/2010CN101791293A Allicin liposome for resisting microbe, protozoan and tumor and preparation method thereof
08/04/2010CN101791289A Ganciclovir resin slow-release suspension and preparation method thereof
08/04/2010CN101647775B Micronomicin sulfate eye drop and preparation method thereof
08/04/2010CN101422484B Nano silver wound-protection anti-inflammation liquid and preparation method thereof
08/04/2010CN101284869B Antiviral polypeptides and use
08/04/2010CN101284020B Chinese medicinal orally-administered preparation for treating the hydrophobia
08/04/2010CN101269193B Liquid medicine for treating kakidrosis of feet
08/04/2010CN101219152B Immune bovine colostrum and method for preparing bifidobacteria composite tiny capsule and pill
08/04/2010CN101129906B Orally taken traditional Chinese medicine composition for treating tuberculosis
08/04/2010CN101100432B Method for synthesizing benzyldimethyl[3-(myristamide)propyl]ammonium chloride
08/04/2010CN101081296B Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof
08/04/2010CN101006860B Smoke-roasting bamboo salt and its making method
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767665 1,3-benzothiazinone derivatives and use thereof
08/03/2010US7767456 Non-viral gene delivery system
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2492724C The use of epidermal growth factor as a gastrointestinal therapeutic agent
08/03/2010CA2490191C Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2386325C Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses
08/03/2010CA2381047C Vaccine against hepatitis b virus and human papilloma virus
08/03/2010CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
08/03/2010CA2343399C Method of vaccination against hsv in human females
08/03/2010CA2262423C Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
08/03/2010CA2230748C Rapamycin formulations for oral administration
07/2010
07/29/2010WO2010085128A2 Processes for preparing hiv reverse transcriptase inhibitors
07/29/2010WO2010085091A2 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084477A1 Anti dengue activity of cissampelos pareira extracts
07/29/2010WO2010084298A1 Stable vaccine compositions and methods of use
07/29/2010WO2010083732A1 N-acetylneuraminic acid compounds, pharmaceutical composition, preparation method and uses thereof
07/29/2010WO2010083728A1 Nanoparticle formulated glycolipid antigens for immunotherapy
07/29/2010WO2010083725A1 Cephalosporin derivatives containing substituted nitrogen-containing fused heterocyclic ring
07/29/2010WO2010083645A1 PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
07/29/2010WO2010083589A1 Biofilm-removing antimicrobial compositions and uses thereof
07/29/2010WO2010051291A8 Besifloxacin ophthalmic composition for the treatment or control of infection
07/29/2010WO2010042919A3 Method of making a vaccine
07/29/2010WO2010042633A3 Naringenin complexes and methods of use thereof
07/29/2010WO2010039545A3 1,2-benzisothiazolinone and isoindolinone derivatives
07/29/2010WO2010033275A3 Orally administerable vaccine for yersinia pestis
07/29/2010WO2010025577A3 Preparation for preventing and/or treating and/or avoiding the spreading of respiratory tract diseases
07/29/2010WO2010022238A9 Anti-flavivirus therapeutic
07/29/2010WO2010014248A3 Antiviral activity of the protein scytovirin and methods of use
07/29/2010WO2010010466A3 Neutralizing anti-influenza a virus antibodies and uses thereof
07/29/2010WO2010006697A3 Powders for reconstitution
07/29/2010WO2009076158A8 Compositions for inducing immune responses
07/29/2010US20100190855 Organic compounds
07/29/2010US20100190842 Influenza polynucleotides, expression constructs, compositions, and methods of use
07/29/2010US20100190785 Method for the purification of mycophenolate mofetil
07/29/2010US20100190779 Viral polymerase inhibitors
07/29/2010US20100190769 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
07/29/2010US20100190766 Antibacterial agents
07/29/2010US20100190748 Boron-containing small molecules
07/29/2010US20100190745 Heterocyclic urea derivatives and methods of use thereof
07/29/2010US20100190735 Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
07/29/2010US20100190726 Novel Phyllanthus Extract
07/29/2010US20100190724 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection
07/29/2010US20100190722 Substance p and thyrotropin releasing hormone for therapeutic applications
07/29/2010US20100190719 Peptides as antimicrobial agents towards campylobacter spp
07/29/2010US20100190713 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent
07/29/2010US20100190712 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine
07/29/2010US20100190711 Big gastrin i as a therapeutic agent
07/29/2010US20100190690 Biomimetic particles and films for pathogen capture and other uses
07/29/2010US20100190232 Functional Mutations In Respiratory Syncytial Virus
07/29/2010US20100189828 Medicinal herbal composition for treating infection
07/29/2010US20100189827 Antiviral composition comprising alnus japonica extracts
07/29/2010US20100189823 Method For Preparing A Hypericum Extract In Neem Oil And A Substance So Obtained
07/29/2010US20100189808 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
07/29/2010US20100189804 Antimicrobial carbon black dispersion
07/29/2010US20100189796 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
07/29/2010US20100189783 Relating to anti-hiv tablet formulations
07/29/2010US20100189772 Compositions of TLR ligands and antivirals
07/29/2010US20100189770 Bioerodible patch
07/29/2010US20100189769 Polypeptide Films and Methods
07/29/2010US20100189748 Inactivated staphylococcal whole-cell vaccine
07/29/2010US20100189746 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures
07/29/2010US20100189744 Papillomavirus vaccine compositions
07/29/2010US20100189742 HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
07/29/2010US20100189741 Oil-in-water emulsion influenza vaccine
07/29/2010US20100189739 Immunogenic compositions comprising dal/dat double mutant, auxotrophic attenuated strains of Listeria and their methods of use
07/29/2010US20100189738 PORIN B (PorB) AS A THERAPEUTIC TARGET FOR PREVENTION AND TREATMENT OF INFECTION BY CHLAMYDIA
07/29/2010US20100189737 Meningococcal vaccines including hemoglobin receptor
07/29/2010US20100189731 Recombinant avian influenza vaccine and uses thereof
07/29/2010US20100189720 Novel card proteins involved in cell death regulation
07/29/2010US20100189718 Molecules with extended half-lives, compositions and uses thereof
07/29/2010US20100189715 Humanized monoclonal antibodies that protect against shiga toxin induced disease
07/29/2010US20100189712 Preparation And Use Of Cell-Synthesized Threads
07/29/2010US20100189690 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
07/29/2010US20100189687 Modulators of pharmacokinetic properties of therapeutics
07/29/2010US20100189686 Albumin Fusion Proteins
07/29/2010US20100189668 Composition for treating herpes simplex viral infections, the method, use and process by which the composition is utilized and the manufacture of the composition
07/29/2010DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses
07/29/2010CA2750340A1 Biofilm-removing antimicrobial compositions and uses thereof
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 1798